Indonesian Political, Business & Finance News

Jiahui Opens International Cell Therapy Centre to Expand Global Access to CAR-T Treatment

| Source: Antara (Indonesian) Translated from Indonesian | Business
Jiahui Opens International Cell Therapy Centre to Expand Global Access to CAR-T Treatment
Image: Antara (Indonesian)

Shanghai (ANTARA/PRNewswire) – Jiahui International Hospital has launched the Jiahui International Cell Therapy Center to expand access to cell therapy for patients from China and other countries, drawing on its experience treating CAR-T cases and its multidisciplinary medical expertise.

The centre was introduced at the inaugural Jiahui International Cell Therapy Summit on 23 October. Jiahui International Hospital held the event with the Jiahui Medical Research & Education Group (J-Med). The livestream attracted registrants from 14 countries and regions.

Professor HAO Siguo, head of the Department of Haematology at the Jiahui International Cancer Center (JICC), and Professor XUAN Linli, head of Medical Oncology at JICC, joined other experts to discuss the use of cell therapy for blood cancers, solid tumours and autoimmune diseases.

Eric J. Rubin, editor-in-chief of the New England Journal of Medicine (NEJM), said the journal had published only one research paper by Chinese scientists about a decade ago. By 2026, the number had exceeded 20. Professor John K. HSIANG, chair of the Jiahui Health Executive Committee, also highlighted China’s progress in medical innovation.

JICC has developed a track record in the use of CAR-T therapy and in treating patients who have achieved good long-term outcomes. In September 2023, it treated China’s first international patient to receive axicabtagene ciloleucel (Axi-Cel) CAR-T therapy. The patient, a woman from Singapore with primary mediastinal large B-cell lymphoma, remains relapse-free more than three years after treatment.

Since then, JICC has provided CAR-T therapy to patients from Singapore, Hong Kong Special Administrative Region, Russia, Hungary, New Zealand, India, Pakistan, the Maldives and other countries and regions. After China approved Satri-cel (CT041) in June 2026 as the world’s first CAR-T therapy for a solid tumour, Jiahui became one of the first institutions to use it in clinical practice. The hospital also treated the first international patient to receive the therapy: a 59-year-old from New Zealand with advanced gastric and duodenal cancer.

Professor Allen WU, president of Jiahui International Hospital, said a surge in demand from international patients was one of the reasons for establishing the centre. The hospital serves nearly 500,000 patient visits each year, with patients from 180 countries and regions. The new centre will link research with clinical care through multidisciplinary collaboration and dedicated services for international patients.

More from 29 October 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/jiahui-opens-international-cell-therapy-centre-to-expand-global-access-to-car-t-treatment-1793260442)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5818895/jiahui-buka-pusat-terapi-sel-internasional-perluas-akses-pengobatan-car-t-secara-global), translated from Indonesian
Print